145 related articles for article (PubMed ID: 6778976)
41. Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat.
Tamarkin L; Cohen M; Roselle D; Reichert C; Lippman M; Chabner B
Cancer Res; 1981 Nov; 41(11 Pt 1):4432-6. PubMed ID: 6796259
[TBL] [Abstract][Full Text] [Related]
42. Antagonistic effects of styrylpyrone derivative (SPD) on 7,12-dimethylbenzanthracene-induced rat mammary tumors.
Hawariah A; Stanslas J
In Vivo; 1998; 12(4):403-10. PubMed ID: 9706492
[TBL] [Abstract][Full Text] [Related]
43. [Effect of malignant tumors with various characteristics on the state of the estradiol receptor system in peripheral target organs].
Savinskaia AP; Boguslavskaia EV
Biull Eksp Biol Med; 1984 Jan; 97(1):79-81. PubMed ID: 6546352
[TBL] [Abstract][Full Text] [Related]
44. Amino and iodotamoxifens: synthesis, estrogen receptor affinity and biodistribution.
Strickland LA; Ponce YZ; Hunter DH; Zabel PL; Powe JE; Morrissey G; Driedger AA; Chamberlain MJ; Tustanoff ER
Drug Des Deliv; 1990 Sep; 6(3):195-212. PubMed ID: 1963782
[TBL] [Abstract][Full Text] [Related]
45. In vivo and in vitro effects of dimethylbenz(a)anthracene on nuclear uptake of estrogen-receptor complex in rat uterus.
Ianicello CM; Okey AB
Oncology; 1976; 33(5-6):225-8. PubMed ID: 829152
[TBL] [Abstract][Full Text] [Related]
46. Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11 beta-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties.
Lobaccaro C; Pons JF; Duchesne MJ; Auzou G; Pons M; Nique F; Teutsch G; Borgna JL
J Med Chem; 1997 Jul; 40(14):2217-27. PubMed ID: 9216841
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of mammary gland tumors by short-term treatment of estradiol-3-benzoate associated with down-regulation of estrogen receptor ERalpha and ERbeta.
Kang JS; Kim S; Che JH; Nam KT; Kim DJ; Jang DD; Yang KH
Oncol Rep; 2004 Oct; 12(4):689-93. PubMed ID: 15375486
[TBL] [Abstract][Full Text] [Related]
48. Studies with 17 beta(16 alpha-[125i]iodo)-estradiol, an estrogen receptor-binding radiopharmaceutical, in rats bearing mammary tumors.
Gatley SJ; Shaughnessy WJ; Inhorn L; Leiberman LM
J Nucl Med; 1981 May; 22(5):459-64. PubMed ID: 7218023
[TBL] [Abstract][Full Text] [Related]
49. Proceedings: Specificity of steroid binding by the oestrogen receptor of rat mammary tumours induced by 7,12-dimethylbenz(a)anthracene.
Powell-Jones W; Davies P; Wilson DW; Griffiths K
J Endocrinol; 1976 Mar; 68(3):30P. PubMed ID: 176305
[No Abstract] [Full Text] [Related]
50. Synthesis, estrogen receptor binding, and tissue distribution of a new iodovinylestradiol derivative (17alpha,20E)-21-[123I]Iodo-11beta-nitrato-19-norp regna-1,3,5 (10),20-tetraene-3,17-diol (E-[123I]NIVE).
Rijks LJ; van den Bos JC; van Doremalen PA; Boer GJ; de Bruin K; Doornbos T; Vekemans JA; Posthumus MA; Janssen AG; van Royen EA
Nucl Med Biol; 1998 May; 25(4):411-21. PubMed ID: 9639304
[TBL] [Abstract][Full Text] [Related]
51. [Estradiol receptors in the plasma membranes of cells in hormone-dependent mammary tumors].
Morozova TM; Volchkov VE; Merkulova TI; Nagibneva IN
Dokl Akad Nauk SSSR; 1983; 272(6):1494-7. PubMed ID: 6418499
[No Abstract] [Full Text] [Related]
52. New iodinated progestins as potential ligands for progesterone receptor imaging in breast cancer. Part 2: In vivo pharmacological characterization.
Rijks LJ; van den Bos JC; van Doremalen PA; Boer GJ; de Bruin K; Janssen AG; van Royen EA
Nucl Med Biol; 1998 Nov; 25(8):791-8. PubMed ID: 9863568
[TBL] [Abstract][Full Text] [Related]
53. Kinetic data of cytoplasmic estradiol receptor.
Görlich M; Kleitke C; Heise E
Endocrinol Exp; 1983 Mar; 17(1):23-31. PubMed ID: 6603347
[TBL] [Abstract][Full Text] [Related]
54. Contribution to the mechanism of Stilbostat action.
Görlich M; Heise E
Neoplasma; 1976; 23(4):363-9. PubMed ID: 1004653
[TBL] [Abstract][Full Text] [Related]
55. Radioiodinated ligands for the estrogen receptor: tissue distribution of 17 alpha-[125I]iodovinylestradiol derivatives in normal and tumor-bearing adult female rats.
Hanson RN; Franke LA; Kaplan M
Int J Rad Appl Instrum B; 1990; 17(2):239-45. PubMed ID: 2111297
[TBL] [Abstract][Full Text] [Related]
56. (2R*,3S*)-1-[125I]Iodo-2,3-bis(4-hydroxyphenyl)pentane ([125I]iodonorhexestrol) and (2R*,3S*)-1-[77Br]Bromo-2,3-bis(4-hydroxyphenyl)pentane ([77Br]bromonorhexestrol), two gamma-emitting estrogens that show receptor-mediated uptake by target tissues in vivo.
Landvatter SW; Katzenellenbogen JA; McElvany KD; Welch MJ
J Med Chem; 1982 Nov; 25(11):1307-12. PubMed ID: 6292424
[TBL] [Abstract][Full Text] [Related]
57. The characteristic binding of catechol estrogens to estrogen receptors in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
Tanaka T; Katoh M; Kubodera A
Steroids; 1986; 48(5-6):361-8. PubMed ID: 2832979
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and pharmacokinetics of 131I labeled benzoyl derivatives of estrone and estradiol.
Brandau W; Eisenhut M; Taylor DM
Int J Appl Radiat Isot; 1985 May; 36(5):379-84. PubMed ID: 3926658
[TBL] [Abstract][Full Text] [Related]
59. The biodistribution of Br-77-labeled estrone: visualization of tissues containing increased estrogen receptors.
Spicer JA; Preston DF; Baranczuk RJ; Harvey E; Guffey MM; Bradshaw DL; Robinson RG
J Nucl Med; 1979 Jul; 20(7):761-5. PubMed ID: 541714
[TBL] [Abstract][Full Text] [Related]
60. Characteristics of binding to estrogen, androgen, progestin, and glucocorticoid receptors in 7,12-dimethylbenz(a)anthracene-induced mammary tumors and their hormonal control.
Asselin J; Melançon R; Moachon G; Bélanger A
Cancer Res; 1980 May; 40(5):1612-22. PubMed ID: 6768450
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
